Skip to main content

Table 2 Anthropometric and metabolic characteristics of patients during the study

From: The effect of lifestyle intervention in obesity on the soluble form of activated leukocyte cell adhesion molecule

Parameter

T0

T1

T2

Friedman Test

P(T0-T1)

P(T1-T2)

P(T0-T2)

Age (years)

42.3 ± 2.2

      

Gender (female/male)

18/11

      

BMI (kg/m2)

46.4 ± 1.7

38.3 ± 1.4

36.3 ± 1.4

***

***

*

***

MAP (mmHg)

109.0 ± 2.6

93.4 ± 2.3

103.5 ± 2.4

***

***

*

n.s.

Fasting glucose (mg/dl)

110.2 ± 7.0

90.7 ± 2.1

89.7 ± 2.2

***

***

n.s.

***

2 h-Glucose OGTT (mg/dl)

117.9 ± 6.6

117.5 ± 4.7

93.2 ± 3.6

***

n.s.

***

***

HOMA-IR

7.8 ± 1.2

3.3 ± 0.3

3.8 ± 0.5

***

***

n.s.

**

T-cholesterol (mg/dl)

192.2 ± 7.6

157.4 ± 5.5

181.0 ± 6.8

***

***

***

n.s.

LDL (mg/dl)

110.3 ± 6.4

98.3 ± 4.5

105.8 ± 5.3

*

**

n.s.

n.s.

HDL (mg/dl)

53.4 ± 4.4

38.9 ± 1.9

53.8 ± 2.6

***

***

***

n.s.

Triglycerides (mg/dl)

149.5 ± 22.9

100.8 ± 5.2

123.9 ± 30.9

**

***

n.s.

**

Adiponectin (μg/ml)

4.8 ± 0.4

6.7 ± 0.5

7.9 ± 0.7

***

***

*

***

Leptin (μg/l)

54.1 ± 5.9

20.5 ± 2.7

32.9 ± 5.8

***

***

**

***

LAR

12.7 ± 1.4

3.5 ± 0.5

5.7 ± 1.1

***

***

*

***

hsCRP (mg/l)

10.1 ± 2.1

6.1 ± 1.1

3.4 ± 0.8

***

*

**

***

  1. Friedman test was used for overall comparison and where significant Wilcoxon signed test was used for comparison between single point measurements. Data represent Mean ± SE. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. = non-significant